Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Delays in Time to Deterioration of Health-Related Quality of Life Were Observed in Patients with Acute Myeloid Leukemia Receiving Venetoclax in Combination with Azacitidine or in Combination with Low-Dose Cytarabine

Blood (2020) 136 (Supplement 1): 33–35.

https://doi.org/10.1182/blood-2020-133912

Published: 2020

Journal Articles

Updated Analysis of Bellini, a Phase 3 Study of Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Blood (2019) 134 (Supplement_1): 1888.

https://doi.org/10.1182/blood-2019-126015

Published: 2019

Journal Articles

Open-Labeled, Multicenter Phase II Study of Bortezomib for Maintenance Therapy in Patients with High Risk Diffuse Large B Cell Lymphoma (DLBCL): Borma Trial from Consortium for Improving Survival of Lymphoma (CISL)

Jae-Cheol Jo, MD, Ho Sup Lee, MD, Cheolwon Suh, Hye Jin Kang, MD PhD, Won Seog Kim, MD PhD, HyeonSeok Eom, MD PhD, Inho Kim, MD PhD, Ho-Jin Shin, MD PhD, Yong Park, Won Sik Lee, MD PhD, Young Rok Do, PhDMD, Lee Gyeong-Won, Sung Yong Oh, Sung-Nam Lim, MD, Seong Yoon Lee, MD

Blood (2019) 134 (Supplement_1): 2884.

https://doi.org/10.1182/blood-2019-132192

Published: 2019

Journal Articles

T(11;14) and High BCL2 Expression Are Predictive Biomarkers of Response to Venetoclax in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Biomarker Analyses from the Phase 3 Bellini Study

Blood (2019) 134 (Supplement_1): 142.

https://doi.org/10.1182/blood-2019-126094

Published: 2019

Journal Articles

Leukemic Stem Cell Phenotype Is Associated with Mutational Profile in Acute Myeloid Leukemia

Ja Min Byun, MD, Dong-Yeop Shin, MD PhD, Youngil Koh, Sung-Soo Yoon, MD PhD, Junshik Hong, MD, Inho Kim, MD PhD

Blood (2019) 134 (Supplement_1): 3852.

https://doi.org/10.1182/blood-2019-126373

Published: 2019

Journal Articles

Physical Function, Pain Severity, and Fatigue in Patients with Relapsed/Refractory Multiple Myeloma: Health-Related Quality of Life Results in Patients Receiving Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone

Cristina Gasparetto, MD, Rakesh Popat, Shaji K. Kumar, MD, Michele Cavo, Javier de la Rubia, MD PhD, Vania T.M. Hungria, MD PhD, Hans Salwender, Kenshi Suzuki, MD PhD, Inho Kim, MD PhD, James Maciel, Liang-Tsai Hsiao, Philippe Moreau, MD, Simon Harrison, MBBS, MRCP, FRCPath, FRACP, PhD, Jia Jia, PhD MBA, Sudeep Karve, PhD, Esprit Ma, Jacob Devine, MA, Katy Benjamin

Blood (2019) 134 (Supplement_1): 3177.

https://doi.org/10.1182/blood-2019-127387

Published: 2019

Journal Articles

Pomalidomide, Cyclophosphamide, and Dexamethasone for Elderly, Transplant-Ineligible Patients with Relapsed and/or Refractory Multiple Myeloma Who Had Failed Treatment with Lenalidomide and Bortezomib: A Study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)

Ho Sup Lee, MD PhD, Chang-Ki Min, MD PhD, Kihyun Kim, MD, Seok Jin Kim, MD PhD, Je-Jung Lee, MD PhD, Inho Kim, MD PhD, Sung-Soo Yoon, MD PhD, Jin Seok Kim, MD PhD, Hyeon-Seok Eom, MD PhD, Dok Hyun Yoon, MD PhD, Cheolwon Suh, Ho-Jin Shin, MD PhD, Yeung-Chul Mun, MD, Min Kyoung Kim, MD PhD, Sung-Nam Lim, MD, Chul Won Choi, Hye Jin Kang, MD PhD

Blood (2019) 134 (Supplement_1): 3114.

https://doi.org/10.1182/blood-2019-122404

Published: 2019

Journal Articles

Genomic and Immune Profiles of Multiple Myeloma Revealed By Whole Genome and Transcriptome Sequencing

Christopher J. Yoon, MPhil, Hyojin Song, Seulki Song, Hyejoo Park, Dong-Yeop Shin, MD PhD, Junshik Hong, MD, Inho Kim, MD PhD, Hyun Jung Lee, MD, Byung-Su Kim, MD PhD, Jung Lim Lee, MD, Sung-Soo Yoon, MD PhD, Young Seok Ju, Youngil Koh, MD PhD

Blood (2018) 132 (Supplement 1): 4493.

https://doi.org/10.1182/blood-2018-99-117546

Published: 2018

Journal Articles

Discovery of Donor Genotype Associated with Long-Term Survival of Patients with Hematopoietic Stem Cell Transplantation in Refractory Acute Myeloid Leukemia

Chan-Young Ock, Heewon Seo, Dae-Yoon Kim, Inho Kim, MD PhD, Sung-Soo Yoon, MD PhD, Ju Han Kim, MD, Youngil Koh, MD

Blood (2017) 130 (Supplement 1): 3303.

https://doi.org/10.1182/blood.V130.Suppl_1.3303.3303

Published: 2017

Journal Articles

Therapy-Related Myeloid Neoplasms Are Not Always Dismal If They Have Better Cytogenetic Profile and Longer Latency Period from Preceding Anti-Cancer Treatment

Junshik Hong, MD, Ji Yun Lee, MD, Ja Min Byun, MD, Dong-Yeop Shin, MDPhD, Youngil Koh, MD, Inho Kim, MD PhD, Sung-Soo Yoon, MD PhD

Blood (2017) 130 (Supplement 1): 1307.

https://doi.org/10.1182/blood.V130.Suppl_1.1307.1307

Published: 2017

Journal Articles

Clinical Dissection of Infectious Event Following ATG Treatment for Aplastic Anemia and Hypoplastic Myelodysplastic Syndrome Reveals Urgent Need for Anti-Aspergillus Prophylaxis

Hee-Ryeong Jang, MD, Sung-Soo Yoon, MD PhD, Inho Kim, MD PhD, Soo-Mee Bang, MD PhD, Junshik Hong, MD, Dong-Yeop Shin, MDPhD, Ji Yun Lee, MD, Jeong-Ok Lee, MD, Byung-Su Kim, MD PhD, Hyo Jung Kim, MD PhD, Wan Beom Park, MD PhD, Nam Joong Kim, MD PhD, Youngil Koh, MD

Blood (2017) 130 (Supplement 1): 2463.

https://doi.org/10.1182/blood.V130.Suppl_1.2463.2463

Published: 2017

Journal Articles

The Role of FDG PET for Evaluation of Bone Marrow Status and Prognosis in T Cell Lymphomas

Go-Un Woo, Jung Min Lee, Youngil Koh, MD, Jin Chul Paeng, Youk Jeonghwan, Sung-Soo Yoon, MD PhD, Inho Kim, MD PhD, Dong-Yeop Shin, MDPhD, Junshik Hong, MD, Hyo Jung Kim, MD PhD, Hyun Jung Lee, MD

Blood (2017) 130 (Supplement 1): 1517.

https://doi.org/10.1182/blood.V130.Suppl_1.1517.1517

Published: 2017

Journal Articles

The Clinical Outcomes of Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Nationwide Registry Study of the Korean Multiple Myeloma Working Party (KMMWP)

Blood (2017) 130 (Supplement 1): 3130.

https://doi.org/10.1182/blood.V130.Suppl_1.3130.3130

Published: 2017

Journal Articles

the Safety and Efficacy of Pomalidomide in Combination with Cyclophosphamide and Dexamethasone (PCD) in the Transplant-Ineligible Patients with Relapsed and/or Refractory Multiple Myeloma (MM) Who Had Lenalidomide Plus Dexamethasone (LD) Following Frontline Bortezomib Combined Chemotherapy, Open-Labeled, Multicenter Phase II Study

Ho Sup Lee, MD, Chang-Ki Min, MD PhD, Kihyun Kim, Seok Jin Kim, MD PhD, Je-Jung Lee, MD PhD, Inho Kim, MD PhD, Jin Seok Kim, MD PhD, Hyeon-Seok Eom, Dok Hyun Yoon, MD PhD, Cheolwon Suh, MD PhD, Ho-Jin Shin, MD, Yeung-Chul Mun, MD PhD, Min Kyoung Kim, MD PhD, Sung-Nam Lim, MD, Chul Won Choi, MD PhD, Hye Jin Kang, MD PhD, Sung-Soo Yoon, MD PhD

Blood (2017) 130 (Supplement 1): 1834.

https://doi.org/10.1182/blood.V130.Suppl_1.1834.1834

Published: 2017

Journal Articles

Mycafungin Prophylaxis for Adult Acute Leukemia Patients Undergoing Induction Chemotherapy

Hyunkyung Park, MD, Youk Jeonghwan, Wan Beom Park, MD PhD, Dong-Yeop Shin, MDPhD, Junshik Hong, MD, Inho Kim, MD PhD, Kim Nam Joong, Hyun Jung Lee, MD, Hyo Jung Kim, MD PhD, Sung-Soo Yoon, MD PhD, Youngil Koh, MD

Blood (2017) 130 (Supplement 1): 5033.

https://doi.org/10.1182/blood.V130.Suppl_1.5033.5033

Published: 2017

Journal Articles

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

Blood (2017) 130 (Supplement 1): 4257.

https://doi.org/10.1182/blood.V130.Suppl_1.4257.4257

Published: 2017

Journal Articles

Receptor Tyrosine Kinase-RAS Pathway Mutation Is Enriched in Myeloid Sarcoma

Mihong Choi, MD, Yoon Kyung Jeon, MDPhD, Choong-Hyun Sun, PhD, Hong-Seok Yun, PhD, Hyun Jung Lee, MD, Junshik Hong, MD, Dong-Yeop Shin, MDPhD, Inho Kim, MD PhD, Sung-Soo Yoon, MD PhD, Youngil Koh, MD

Blood (2017) 130 (Supplement 1): 2672.

https://doi.org/10.1182/blood.V130.Suppl_1.2672.2672

Published: 2017

Journal Articles

Real World Treatment Outcomes of Multiple Myeloma in Korea

Ja Min Byun, Sung-Soo Yoon, Dong-Yeop Shin, MD PhD, Youngil Koh, MD PhD, Inho Kim, MD PhD, Hyun Kyung Kim, Dong Soon Lee, Jung-Lim Lee, Byung Su Kim

Blood (2016) 128 (22): 2367.

https://doi.org/10.1182/blood.V128.22.2367.2367

Published: 2016

Journal Articles

Comparison of Clinical Diagnosis for Hereditary Spherocytosis with Molecular Diagnosis By Multi-Gene Target Sequencing in Korea

Hyoung Soo Choi, MD PhD, Qute Choi, MD PhD, Jung Ah Kim, Kyong Ok Im, MT, Si Nae Park, Yoomi Park, Ju Han Kim, MD PhD, Hee Young Shin, MD PhD, Seon Young Kim, MD PhD, Hyoung Jin Kang, MD PhD, Hoon Kook, MD, Soo-Jeong Kim, MD, Inho Kim, MD PhD, Ji Yoon Kim, MD, Hawk Kim, Kyung Duk Park, MD PhD, Kyung Bae Park, MD PhD, Meerim Park, MD PhD, Sang Kyu Park, MD, Eun Sil Park, MD PhD, Jeong-A Park, MD PhD, Ji Kyoung Park, MD, Hee Jo Baek, MD PhD, Jeong Ho Seo, MD, Ye Jee Shim, MD PhD, Hyo Seop Ahn, MD PhD, Keon Hee Yoo, MD PhD, Hoi Soo Yoon, MD PhD, Kun Soo Lee, MD PhD, Kwang Chul Lee, MD PhD, Jae Min Lee, MD, Mee Jeong Lee, MD PhD, Sun Ah Lee, MD, Jun Ah Lee, MD PhD, Jae Hee Lee, MD, Ji Won Lee, MD PhD, Young-Woong Won, MD, Young Tak Lim, MD, Hyun Joo Jung, MD, Hee Won Cheuh, MD PhD, Eun Jin Choi, MD PhD, Hye Lim Jung, MD PhD, Dong Soon Lee, The Hereditary Hemolytic Anemia Working Party of the Korean Society of Hematology

Blood (2016) 128 (22): 1243.

https://doi.org/10.1182/blood.V128.22.1243.1243

Published: 2016

Journal Articles

Predictors of General Discomfort, Limitations in Activities of Daily Living, and Intention of a Second Donation in Unrelated Hematopoietic Stem Cell Donation

Mark Lee, Jin Ho Jang, Hyo Jin Min, PhD, Hyung In Jang, Jung Hwa Nah, Chuhl Joo Lyu, MD PhD, Kyou Sup Han, MD PhD, Jong-Ho Won, MD, Young Ho Lee, MD PhD, So Young Chong, MD, Yeung Chul Mun, MD PhD, Won Sik Lee, MD PhD, Seok Jin Kim, Inho Kim, MD PhD

Blood (2016) 128 (22): 3375.

https://doi.org/10.1182/blood.V128.22.3375.3375

Published: 2016

NARROW

Delays in Time to Deterioration of Health-Related Quality of Life Were Observed in Patients with Acute Myeloid Leukemia Receiving Venetoclax in Combination with Azacitidine or in Combination with Low-Dose Cytarabine

Updated Analysis of Bellini, a Phase 3 Study of Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Open-Labeled, Multicenter Phase II Study of Bortezomib for Maintenance Therapy in Patients with High Risk Diffuse Large B Cell Lymphoma (DLBCL): Borma Trial from Consortium for Improving Survival of Lymphoma (CISL)

T(11;14) and High BCL2 Expression Are Predictive Biomarkers of Response to Venetoclax in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Biomarker Analyses from the Phase 3 Bellini Study

Leukemic Stem Cell Phenotype Is Associated with Mutational Profile in Acute Myeloid Leukemia

Physical Function, Pain Severity, and Fatigue in Patients with Relapsed/Refractory Multiple Myeloma: Health-Related Quality of Life Results in Patients Receiving Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone

Pomalidomide, Cyclophosphamide, and Dexamethasone for Elderly, Transplant-Ineligible Patients with Relapsed and/or Refractory Multiple Myeloma Who Had Failed Treatment with Lenalidomide and Bortezomib: A Study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)

Genomic and Immune Profiles of Multiple Myeloma Revealed By Whole Genome and Transcriptome Sequencing

Discovery of Donor Genotype Associated with Long-Term Survival of Patients with Hematopoietic Stem Cell Transplantation in Refractory Acute Myeloid Leukemia

Therapy-Related Myeloid Neoplasms Are Not Always Dismal If They Have Better Cytogenetic Profile and Longer Latency Period from Preceding Anti-Cancer Treatment

Clinical Dissection of Infectious Event Following ATG Treatment for Aplastic Anemia and Hypoplastic Myelodysplastic Syndrome Reveals Urgent Need for Anti-Aspergillus Prophylaxis

The Role of FDG PET for Evaluation of Bone Marrow Status and Prognosis in T Cell Lymphomas

The Clinical Outcomes of Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Nationwide Registry Study of the Korean Multiple Myeloma Working Party (KMMWP)

Mycafungin Prophylaxis for Adult Acute Leukemia Patients Undergoing Induction Chemotherapy

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

Receptor Tyrosine Kinase-RAS Pathway Mutation Is Enriched in Myeloid Sarcoma

Real World Treatment Outcomes of Multiple Myeloma in Korea

Comparison of Clinical Diagnosis for Hereditary Spherocytosis with Molecular Diagnosis By Multi-Gene Target Sequencing in Korea

Predictors of General Discomfort, Limitations in Activities of Daily Living, and Intention of a Second Donation in Unrelated Hematopoietic Stem Cell Donation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only